This company listing is no longer active
Advanced Proteome Therapeutics Management
Management criteria checks 2/4
Advanced Proteome Therapeutics' CEO is Paul John Woodward, appointed in Dec 2018, has a tenure of 5.25 years. directly owns 1.15% of the company’s shares, worth €1.61K. The average tenure of the management team and the board of directors is 5.3 years and 5.3 years respectively.
Key information
Paul John Woodward
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 5.3yrs |
| CEO ownership | 1.2% |
| Management average tenure | 5.3yrs |
| Board average tenure | 5.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Apr 30 2023 | n/a | n/a | -US$2m |
| Jan 31 2023 | n/a | n/a | -US$1m |
| Oct 31 2022 | n/a | n/a | -US$126k |
| Jul 31 2022 | US$70k | US$70k | US$760k |
| Apr 30 2022 | n/a | n/a | US$987k |
| Jan 31 2022 | n/a | n/a | -US$216k |
| Oct 31 2021 | n/a | n/a | -US$816k |
| Jul 31 2021 | US$56k | US$56k | -US$2m |
| Apr 30 2021 | n/a | n/a | -US$2m |
| Jan 31 2021 | n/a | n/a | -US$634k |
| Oct 31 2020 | n/a | n/a | -US$775k |
| Jul 31 2020 | US$44k | US$44k | -US$451k |
| Apr 30 2020 | n/a | n/a | -US$476k |
| Jan 31 2020 | n/a | n/a | -US$395k |
| Oct 31 2019 | n/a | n/a | -US$154k |
| Jul 31 2019 | US$82k | US$30k | -US$333k |
| Apr 30 2019 | n/a | n/a | -US$498k |
| Jan 31 2019 | n/a | n/a | -US$29k |
| Oct 31 2018 | n/a | n/a | -US$796k |
| Jul 31 2018 | US$3k | n/a | -US$745k |
Compensation vs Market: Insufficient data to establish whether Paul John's total compensation is reasonable compared to companies of similar size in the German market.
Compensation vs Earnings: Paul John's compensation has increased whilst the company is unprofitable.
CEO
Paul John Woodward (61 yo)
5.3yrs
Tenure
US$70,284
Compensation
Mr. Paul John Courtney Woodward has been Chief Financial Officer and Director at Railtown AI Technologies Inc. since July 2016 and served as its President and Chief Executive Officer from August 18, 2016 u...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.3yrs | US$70.28k | 1.15% € 1.6k | |
| Chief Financial Officer | 15yrs | US$17.77k | 0.49% € 680.6 | |
| Secretary & Independent Director | 5.3yrs | no data | 1.33% € 1.9k |
5.3yrs
Average Tenure
61yo
Average Age
Experienced Management: 0E81's management team is seasoned and experienced (5.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 11.8yrs | US$70.28k | 1.15% € 1.6k | |
| Secretary & Independent Director | 5.3yrs | no data | 1.33% € 1.9k | |
| Member of Corporate Advisory Board | 9yrs | no data | no data | |
| Independent Director | 5.3yrs | no data | 0.75% € 1.1k | |
| Director | 1.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 5.8yrs | no data | no data | |
| Director | no data | no data | no data | |
| Member of Scientific Advisory Board | 2.8yrs | no data | no data |
5.3yrs
Average Tenure
61yo
Average Age
Experienced Board: 0E81's board of directors are considered experienced (5.3 years average tenure).